About ▼ Careers Internship MedBlog Contact us

LOGIN REGISTER

Medindia » News » Drug News » FDA Issues Warning About Risk of Abnormal Heart Rhythm With Celexa Use

FDA Issues Warning About Risk of Abnormal Heart Rhythm With Celexa Use

by Kathy Jones on Aug 25 2011 6:57 PM

FDA Issues Warning About Risk of Abnormal Heart Rhythm With Celexa Use

The US Food and Drug Administration has warned against taking high doses of the popular antidepressant, Celexa and said that it could lead to abnormal heart rhythms that could turn fatal.

The warning comes after it was found that doses of Celexa in excess of 40mg a day can interfere with the electrical activity in the heart that could lead to abnormal rhythm. Known as arrhythmia, the condition is known to result in cardiac arrests and death.

Depression - Types, Causes, Symptoms, Diagnosis, Treatment

Depression - Types, Causes, Symptoms, Diagnosis, Treatment
Depression is one of the most common mental disorders affecting approximately 340 million people in the world. No one is immune from depression - it occurs in people of all social classes, all countries and all cultural settings.

Celexa belongs to a class of drugs called selective serotonin reuptake inhibitors (SSRIs). These drugs are commonly used to treat depression. Other popular drugs in this class include Paxil, Prozac and Zoloft.

Source-Medindia

Adolescent Depression - Causes - Affects - Depressed Teens - Treatment - FAQs

Adolescent Depression - Causes - Affects - Depressed Teens - Treatment - FAQs
Adolescent depression is an ailment that occurs during the teenage characterized by persistent melancholy, disappointment and loss of self-esteem.

Depression � A Holistic Approach-Signs, Symptoms and Treatment

Depression � A Holistic Approach-Signs, Symptoms and Treatment
Depression is a common disorder and many worldwide suffer from depression. Early recognition of symptoms and signs of depression can help in taking a holistic approach to the management of depression.

Recommended Readings

Mitral Valve Prolapse

Mitral Valve Prolapse

Mitral Valve Prolapse is a relatively common condition and causes leakage of blood through the valve. MVP is not life-threatening in most instances.

Blue Man Syndrome and Amiodarone

Blue Man Syndrome and Amiodarone

Long-term use of amiodarone, a drug used for abnormal heart rhythm can cause bluish discoloration of the skin leading to blue man syndrome.

Heart Rate and Heart Rhythm

Heart Rate and Heart Rhythm

Normal heart rate and rhythm can be measured by checking pulse on the wrist and evaluated with an electrocardiogram. Myths about heart rate can lead to anxiety.

Pericarditis

Pericarditis occurs when the pericardium gets inflamed. Pericarditis is characterized by severe chest pain.

Palpitations Symptom Evaluation

Palpitations Symptom Evaluation

The cause of palpitations is diagnosed based on the history of the patient, and heart and blood tests.

Aortic Valve Stenosis

Aortic Valve Stenosis

Aortic valve Stenosis is an abnormal narrowing of the c valve. Symptoms include angina, and that of heart failure. Aortic valve replacement is effective therapy.

Latest Drug News

Alectinib: Adjuvant Treatment for Lung Cancer Approved by US FDA

Alectinib: Adjuvant Treatment for Lung Cancer Approved by US FDA

Alectinib approved by US FDA for auxiliary treatment of patients with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) who underwent tumor resection.

US FDA Approval of N-803: Ray of Hope For Bladder Cancer Patients

US FDA Approval of N-803: Ray of Hope For Bladder Cancer Patients

The US FDA approves a immunotherapy drug, N-803, for BCG-unresponsive non-muscle invasive bladder cancer, suggested to be used in conjunction with BCG.

Resmetirom For MASH: Approved by US FDA, Increase in Partnerships

Resmetirom For MASH: Approved by US FDA, Increase in Partnerships

The increasing trend in strategic partnerships between innovator companies, and the US FDA approval for Rezdiffra has led to a boost in the development of medications for MASH.

Semaglutide: A Dominant Player for Patients With Heart Failure

Semaglutide: A Dominant Player for Patients With Heart Failure

Data provesSemaglutideefficacy in treatment of Type 2 diabetes, obesity, heart failure, and chronic kidney failure, it emerges as important therapy in metabolic syndrome.

Physician's Lack Agreement – Patients Prefer Branded or Generic Drugs?

Physician's Lack Agreement – Patients Prefer Branded or Generic Drugs?

Generics are not widely used, despite cost advantage, due to a lack of information to patients and reluctance from physicians to prescribe generics - A Need to educate masses

Advertisement